Navigation Links
Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
Date:4/1/2008

ncluding digital imaging and standard quality of life measurement such as the six-minute walking test, New York Heart Association (NYHA) heart failure classification and Minnesota Living with Heart (MLHF) questionnaire. Final six-month results observed in the SEISMIC Trial include:

-- 84 percent of treated patients experienced improved or unchanged six-

minute walking test scores compared to 16 percent of the control group

- 69 percent of the control group's results worsened, versus only 16

percent of the treated group

-- 94 percent of treated patients experienced improved or unchanged NYHA

classification compared to 58 percent of the control group

- 42 percent of the control group's results worsened, versus only 6

percent of the treated group

Prof. Serruys also noted that reports of arrhythmia among the patients evaluated in SEISMIC, both in terms of total number of episodes as well as timing of episodes, were no different between the treatment and control arms in the study. This suggests that MyoCell is not associated with a higher prevalence of arrhythmias; rather, that arrhythmias are an expected occurrence for this subset of heart failure patients.

"These data support the need for a randomized, double-blind, placebo- controlled study involving the MyoCell technology," said Prof. Serruys. "We look forward to applying our learning from this trial to the larger, more comprehensive MARVEL(2) Trial currently underway in the U.S. and Europe." The MARVEL Trial, a randomized, double-blind, placebo-controlled, multi-center Phase II/III Trial involving 330 patients in North America and Europe, is the largest trial of its kind to date. Enrollment in the MARVEL Trial began in October 2007, targeting patients who fall into Class II or III heart failure. The MARVEL Trial will further study the safety and efficacy of the minimally invasive MyoCell autologous stem-cell th
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
2. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
3. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
4. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
5. TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials
6. Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
7. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
8. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
9. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
10. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
11. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015 "Whether it,s our family, ... day." In a single sentence, Dr. ... officer at Pfizer,s Centers for Therapeutic Innovation ... fueling progress at America,s biopharmaceutical companies. ... with academia, patient foundations and the National Institutes of ...
(Date:3/26/2015)... 26, 2015 When they began experiencing ... PACS vendor their system would no longer be ... needed a better structured solution to support their ... due to its interface capabilities and its 2014 ... through to the hospital,s radiology department. Avreo,s experienced ...
(Date:3/26/2015)... 26, 2015 Zimmer Holdings, Inc. (NYSE and ... Advanced Bearing Technology with Vitamin E by celebrating ... earlier this month reported that, at 96 million cycles ... Bearing Technology featuring Vitamin E grafted highly crosslinked polyethylene ... rate reduction of 95 percent, with no cracking, delamination ...
Breaking Medicine Technology:Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3
... Ferring Pharmaceuticals Inc. today announced publication of one ... (tranexamic acid) tablets for cyclic heavy menstrual bleeding ... journal, Obstetrics & Gynecology .  The six-month ... blood loss from baseline, and improved health-related quality-of-life ...
... Oct. 6 AstraZeneca (NYSE: AZN ... at no cost to qualifying patients at the ... (Logo: http://photos.prnewswire.com/prnh/20091027/PH99766LOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) ... is an expansion of its AZ&Me™ Prescription Savings ...
Cached Medicine Technology:Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study 2Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study 3Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study 4AstraZeneca and the Sacramento County Pharmacy Provide Free Medicines to Eligible California Patients 2AstraZeneca and the Sacramento County Pharmacy Provide Free Medicines to Eligible California Patients 3
(Date:3/26/2015)... March 26, 2015 Dr. Rod ... annual Dallas Rhinoplasty Symposium and has trained over ... the importance of evidence based medicine (EBM), that is, ... well conducted research. , "We often hear from ... and while we are certainly not trying to stifle ...
(Date:3/26/2015)... North American Seminars launches it new mobile website ... information regarding OT PT continuing education courses to the ... leader in live hands PT continuing education courses ... online continuing education courses. , Featured Live ... Clinicians Approach to Advanced Concepts in Examination and Treatment ...
(Date:3/26/2015)... 2015 The American College of Traditional Chinese ... topics of the DAOM Program as well as Marketing Basics ... will be hosted by Dr. Carla Wilson, who will give ... on how to prepare for the spring quarter. The webinar ... 27, April 1 and April 3. Attendees can log in ...
(Date:3/26/2015)... Doctors Scott Sullivan and Frank DellaCroce, Co-Founders of the ... the St. Charles Surgical Hospital (SCSH) in ... Surgical Oncologist Dr. William Karl Ordoyne has joined their ... surgical oncologist Alan Stolier, M.D., FACS and the team ... Sullivan, M.D., FACS; Chris Trahan, M.D., FACS; M. Whitten ...
(Date:3/26/2015)... Doylestown, PA (PRWEB) March 26, 2015 ... recruited a new team of nationally renowned scientists to ... hepatitis B, a move that nearly triples its research ... scientists focusing solely on hepatitis B and liver cancer ... Drs. Timothy Block, Jinhong Chang, Ju Tao Guo and ...
Breaking Medicine News(10 mins):Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 3Health News:ACTCM Announces Upcoming Webinars 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 2Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 4
... study published in the Lancet has revealed how British American ... strategy to mask the toxicity of the manufactured cigarettes. // ... of the company by Canadian researchers, it has been found ... nicotine under real life situations, while in documentation, it was ...
... at the University of Iowa Roy J. and Lucille A. ... (PET) technology can help // doctors gauge the response of ... and co-author Bruce Cheson, M.D., of the Lombardi Comprehensive Cancer ... usage of PET n gauging the response of the tumor ...
... service policy acceptance in schools it has been found ... directors' perceptions. // ,They have different ideas ... among key stakeholders addressing new wellness policy development mandated ... 2004. ,'Competitive foods are those sold ...
... respiratory illness as a result of breast-feeding, according to a ... belonging to the age group of 6 years to 24 ... They identified five groups, formula-fed only, full breastfeeding for ... months, full breastfeeding from four to less than six months, ...
... the wrong reasons. Blaming the government of apathy over the ... post of Chief Scientific Officer at the Department of Health, has ... vaccine adequately, despite a lurking fear of autism, as a probable ... it could turn out to be the worst disgrace in medical ...
... Health Grade, a health ratings company, the top 5 % ... to lower the risk of death to patients by ... risk of complications. //,Health Grades, as part of their ... in the United States. ,Death and complication rates for ...
Cached Medicine News:Health News:Clash of Difference of perceptions in food policy among Principals’ and Director 2
... These markers are available with 16 or 24 ... 6.5mm diameter, and an outer 9.5mm diameter. The markers ... in one single step for a 16 or 24 ... outer points on the cornea to achieve a precise ...
... Micro Shafts For Insertion Through A 1.0mm ... ... For A More Comfortable Approach., ,Recessed Jaws ... Supplied For Protection Of Jaws During Sterilization., ...
... New advancements in diamond technology allow ... used at a more economical cost. Proven ... healing, and insures a superior postoperative result. ... available in a variety of widths and ...
The New Easy-To-Use Disposable Diamond Knife Cleaning System Can Remove Even Baked-On Debris In Seconds. It Is Much More Effective Than Steam Or Blocks Of Styrofoam, Much Safer For Employees As Wel...
Medicine Products: